trending Market Intelligence /marketintelligence/en/news-insights/trending/Si7YiJSbKz6yBqoyPvELBA2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Organovo to market tissue testing service in Japan

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Organovo to market tissue testing service in Japan

Organovo Holdings Inc. engaged Cosmo Bio Co. Ltd. to market and distribute its NovoView preclinical services in Japan.

The company will work with Cosmo's drug discovery services team to further its 3D bioprinting technology for testing kidney and liver tissue.